Inhibition of complement by a series of substituted 2-aryl-1,3-indandiones: interaction with the fifth component of complement

Molecular Immunology
S S AsgharH Timmerman

Abstract

A series of substituted 2-aryl-1,3-indandiones were investigated for their ability to inhibit the complement system. Some of them were found to be considerably strong inhibitors. The inhibitory activity was mainly dependent on substitutions at positions 3 and 5 of the phenyl ring. 3,5-dichloro-(8), 3,5-bis(trifluoromethyl)- (7), 3,5-diisopropyl- (3) and 3,5-di-t-butyl- (5) phenylindandiones were the strongest inhibitors of the series. The generation of EAC1-5 cells from EAC1-3 cells and C5 was most strongly inhibited by these compounds although some inhibition of the interaction of EAC1-5 with C6-C9 and EAC1-6 with C7-C9 was also observed. Slight inhibition at other steps of complement activation was also seen but this was not considered to be appreciable. Dialysis of normal serum or purified C5 pre-incubated with compounds 3, 5, 7 and 8 did not cause recovery of the hemolytic activity of normal serum or purified C5. Thus, the main site of inhibition in the complement cascade appeared to be at C5. The total alternative pathway was also inhibited to some extent by these compounds, probably due to their interaction with C5.

References

Jan 1, 1965·Annual Review of Microbiology·L T Rosenberg
Jun 5, 1982·Lancet·P Emery, R Grahame
Apr 12, 2001·The New England Journal of Medicine·M J Walport
Oct 1, 1955·Biochimica Et Biophysica Acta·L LEVINE
Apr 1, 1964·Proceedings of the Society for Experimental Biology and Medicine·G M GNESHW DECHER
Aug 30, 1973·Biochimica Et Biophysica Acta·S S AsgharR H Cormane
Apr 13, 2011·Purinergic Signalling·Kenneth A JacobsonStefano Costanzi

❮ Previous
Next ❯

Citations

Dec 7, 2007·Bioorganicheskaia khimiia·L V KozlovA P Kaplun

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.